By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS




Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





Company News
ImmunoGen (IMGN) Announces $200 Million Non-Dilutive Royalty Transaction 3/30/2015 12:30:47 PM
ImmunoGen (IMGN) Jumps After Reaching $220 Million Cancer Deal With Takeda (TKPYY) 3/23/2015 6:18:00 AM
ImmunoGen, Inc. (IMGN) Announces Presentations At Upcoming American Association for Cancer Research Annual Meeting 2015 3/19/2015 10:52:21 AM
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentation At Upcoming Investor Conference 2/25/2015 11:04:40 AM
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentations At Upcoming Investor Conferences 2/4/2015 10:48:45 AM
ImmunoGen, Inc. (IMGN) Reports Second Quarter Fiscal Year 2015 Financial Results 1/30/2015 11:10:20 AM
ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2015 Financial Results 1/22/2015 10:56:43 AM
ImmunoGen, Inc. (IMGN) Appoints Richard J. Gregory, Ph.D. As EVP, Chief Scientific Officer; John M. Lambert, Ph.D. Named EVP, Distinguished Research Fellow 12/22/2014 9:50:04 AM
ImmunoGen, Inc. (IMGN) Reports Roche (RHHBY) Has Provided An Update On The MARIANNE Trial 12/19/2014 11:27:56 AM
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentation At The 33rd Annual J.P. Morgan Healthcare Conference 12/16/2014 10:13:03 AM
12345678910...
//-->